Trial: 202008198

A Phase 1 Study to Evaluate Safety, Tolerability,Pharmacokinetics and Pharmacodynamics of AMG 256 in Patients With Advanced Solid
Tumors

Phase

I

Principal Investigator

Govindan, Ramaswamy

Disease Site

Kidney; Lip, Oral Cavity and Pharynx; Lung; Lung Cancer – Non-small Cell; Melanoma, Skin; Other Skin

Learn more about this study at: clinicaltrials.gov